Sponsor | Principal investigator, centre | Disease, application |
---|---|---|
European Organization for Research and Treatment of Cancer | The Netherlands Cancer Institute, Amsterdam, The Netherlands | Breast cancer, comparing van't Veer and van de Vijver prognostic signature to St Gallen criteria |
Avon Foundation | Daniel Haber, Massachusetts General Hospital, Boston, MA, USA | Breast cancer, validating van't Veer and van de Vijver prognostic signature |
Breast Cancer Research Foundation, Millennium Pharmaceuticals | Lajos Pusztai, Anderson Cancer Center, Houston, TX, USA | Breast cancer, validating own signature for predicting drug response |
Millennium Pharmaceuticals | Kenneth Anderson, Dana-Farber Cancer Center, Boston, MA, USA | Multiple myeloma, validating own signature for response to Velcade |
National Cancer Institute | Jenny Chang, Baylor College of Medicine, Houston, TX, USA | Breast cancer, validating own 90-gene prognostic signature |